Item 7.01 Regulation FD Disclosure.
On April 1, 2020, TELA Bio, Inc. (the "Company") updated information reflected
in a corporate slide deck, which representatives of the Company will use in
various meetings with investors from time to time. A copy of the presentation is
attached hereto as Exhibit 99.1, and incorporated herein by reference.
The information furnished pursuant to Item 7.01, including Exhibit 99.1, shall
not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act
of 1934, as amended (the "Exchange Act"), or otherwise subject to the
liabilities of that section, and shall not be deemed to be incorporated by
reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as expressly set forth by specific reference in such
Item 9.01 Financial Statements and Exhibits.
The following exhibits are being filed herewith:
99.1 Corporate Slide Deck, dated April 1, 2020.
© Edgar Online, source Glimpses